Advertisement
News
Advertisement

PositiveID Corporation and Siemens AG Enter Into Agreement to Expand PositiveID's Wireless Body Platform

Tue, 01/04/2011 - 4:34am
PositiveID
DELRAY BEACH, Fla., Jan. 4, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (Nasdaq:PSID), the leader in next generation patient monitoring, announced today that it has entered into an agreement with Siemens AG ("Siemens") related to its Wireless Body™ platform. The license agreement allows PositiveID to expand its personalized medicine and smart healthcare applications for next generation patient monitoring and includes granting PositiveID rights to utilize key intellectual property, and, in particular, Siemens' Patent No. 7,650,888, titled "Method and System for Identification of a Medical Implant" using RFID (radio frequency identification). 

PositiveID's focus is to use the technology to improve disease management and overall wellness through the effortless identification of implantable medical devices within the body. This application expands PositiveID's Wireless Body, an integrated, in vivo and external, smart healthcare communication system that has the ability to deliver personalized medical solutions wirelessly.

The Wireless Body communication system is based on PositiveID's Patent No. 7,125,382 for an Embedded Bio-Sensor System, and builds upon existing technology and intellectual property portfolio of PositiveID, the developer of the world's first and only health-related implantable RFID microchip cleared by the U.S. Food and Drug Administration. The Wireless Body platform will be designed to enhance wellness and disease management, for diabetes and other chronic illnesses, by allowing healthcare systems to communicate with each other and monitor patients seamlessly.

Scott R. Silverman, Chairman and CEO of PositiveID, said, "We are excited for this opportunity to work together with Siemens and employ their patented technology to rapidly develop our Wireless Body platform. We believe that we are well positioned as a next generation leader in mobile health and personalized sensor tools, with the ability to wirelessly monitor patients, their vital signs and their medical devices via The Wireless Body."

The Wireless Body also has the ability to identify medical devices, currently catheter ports, to allow them to communicate with an external reader to ensure proper medication dosages and safety for the patient.

About Siemens AG

Siemens AG (Berlin and Munich) is a global powerhouse in electronics and electrical engineering, operating in the industry, energy and healthcare sectors. For over 160 years, Siemens has stood for technological excellence, innovation, quality, reliability and internationality. The company is the world's largest provider of environmental technologies, generating some €28 billion - more than one-third of its total revenue - from green products and solutions. In fiscal 2010, which ended on September 30, 2010, revenue totaled €76 billion and net income €4.1 billion. At the end of September 2010, Siemens had around 405,000 employees worldwide. Further information is available on the Internet at: www.siemens.com.

About PositiveID Corporation

PositiveID Corporation develops and markets healthcare and information management products through its RFID-based diagnostic devices and identification technologies, and its proprietary disease management tools. PositiveID's implantable healthcare devices and external hardware and software products are designed to communicate wirelessly to improve healthcare and the patient's quality of life. For more information on PositiveID, please visit www.positiveidcorp.com

SOURCE
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading